Form 4: PACS Director Dilsaver Granted 4,399 Restricted Stock Units
Insider Transaction Report
PACS Group, Inc. Director Evelyn S. Dilsaver was granted 4,399 restricted stock units, increasing her beneficial ownership to 27,138 shares.
Summary
- Evelyn S. Dilsaver, a Director of PACS Group, Inc., was granted 4,399 shares of Common Stock in the form of Restricted Stock Units (RSUs).
- The transaction date for this acquisition was December 19, 2025.
- Following this transaction, Ms. Dilsaver's direct beneficial ownership of Common Stock increased to 27,138 shares.
- The RSUs will vest 100% on the earlier of December 19, 2026, or the date of the next annual meeting following the grant date, contingent on Ms. Dilsaver's continued service to the Issuer.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The filing reports a routine equity compensation grant to a director, which is a standard corporate governance practice. It indicates continued alignment of director interests with shareholders but does not convey significant new operational or financial news.
Positives
- Director Evelyn S. Dilsaver's beneficial ownership increased by 4,399 shares through an RSU grant, aligning her interests further with shareholders.
- The grant of RSUs is a common form of equity compensation, indicating ongoing commitment to retaining and incentivizing key personnel.
Future Outlook
The granted Restricted Stock Units are set to vest 100% on the earlier of December 19, 2026, or the date of the next annual meeting following the grant date, contingent on the director's continued service.
Industry Context
The grant of Restricted Stock Units to a director is a standard practice in corporate governance across various industries, used to align management and director incentives with long-term shareholder value.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of director compensation is a widely accepted practice, comparable to compensation structures seen in companies like Healthpeak Properties (PEAK) or Welltower Inc. (WELL) within the healthcare real estate and services sector, which often utilize equity awards to incentivize long-term performance and retention.
- The vesting schedule, tied to continued service and a specific future date or the next annual meeting, is typical for such grants, ensuring commitment from the director.
Related Party Transactions
- The RSU grant to Director Evelyn S. Dilsaver represents a compensation transaction between the company and a related party (a director).
Stakeholder Impact
- Shareholders: The grant aligns the director's long-term interests with shareholder value through equity ownership, potentially fostering more prudent decision-making.
- Employees: No direct impact on general employees is indicated by this specific filing.
Next Steps
- The 4,399 Restricted Stock Units will vest on the earlier of December 19, 2026, or the date of the next annual meeting following the grant date, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 12/19/2025 | Grant date of 4,399 Restricted Stock Units (RSUs) to Director Evelyn S. Dilsaver. |
| 12/19/2026 | Earliest vesting date for 100% of the granted RSUs, subject to continued service. |
| Date of next annual meeting following the grant date | Alternative vesting date for 100% of the granted RSUs, if earlier than December 19, 2026, subject to continued service. |
Keywords
PACS Group, PACS, Evelyn Dilsaver, Restricted Stock Units, RSU grant, insider transaction, director compensation, equity compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.